Healthcare provider profile · identity verified

Lucas Edwards

Physician Assistant · GODFREY, IL · NPI 1790315018

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	290	93
Levothyroxine Sodium	Levothyroxine Sodium	263	75
Amlodipine Besylate	Amlodipine Besylate	221	70
Lisinopril	Lisinopril	186	61
Albuterol Sulfate Hfa	Albuterol Sulfate	180	59
Omeprazole	Omeprazole	141	52
Metformin Hcl	Metformin Hcl	138	44
Simvastatin	Simvastatin	138	41
Losartan Potassium	Losartan Potassium	136	44
Gabapentin	Gabapentin	116	34
Meloxicam	Meloxicam	110	39
Metoprolol Succinate	Metoprolol Succinate	109	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	26
Furosemide	Furosemide	90	30
Fluticasone Propionate	Fluticasone Propionate	85	37
Famotidine	Famotidine	81	27
Pantoprazole Sodium	Pantoprazole Sodium	81	31
Hydrochlorothiazide	Hydrochlorothiazide	79	29
Tramadol Hcl	Tramadol Hcl	78	25
Potassium Chloride	Potassium Chloride	73	26
Sertraline Hcl	Sertraline Hcl	73	22
Trazodone Hcl	Trazodone Hcl	72	27
Alprazolam	Alprazolam	69	21
Bupropion Xl	Bupropion Hcl	67	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	26
Lorazepam	Lorazepam	57	13
Carvedilol	Carvedilol	56	17
Metoprolol Tartrate	Metoprolol Tartrate	56	19
Rosuvastatin Calcium	Rosuvastatin Calcium	55	17
Ozempic	Semaglutide	54	suppressed
Buspirone Hcl	Buspirone Hcl	52	14
Citalopram Hbr	Citalopram Hydrobromide	52	18
Tamsulosin Hcl	Tamsulosin Hcl	51	18
Duloxetine Hcl	Duloxetine Hcl	49	17
Montelukast Sodium	Montelukast Sodium	49	13
Pravastatin Sodium	Pravastatin Sodium	49	20
Eliquis	Apixaban	48	16
Alendronate Sodium	Alendronate Sodium	47	14
Xarelto	Rivaroxaban	46	12
Lovastatin	Lovastatin	45	suppressed
Ibuprofen	Ibuprofen	44	11
Naproxen	Naproxen	44	20
Atenolol	Atenolol	43	11
Clopidogrel	Clopidogrel Bisulfate	43	14
Fenofibrate	Fenofibrate	43	14
Jardiance	Empagliflozin	43	suppressed
Prednisone	Prednisone	43	29
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	14
Ezetimibe	Ezetimibe	38	17
Mirtazapine	Mirtazapine	38	11
Ropinirole Hcl	Ropinirole Hcl	38	11
Methylprednisolone	Methylprednisolone	37	36
Spironolactone	Spironolactone	37	suppressed
Allopurinol	Allopurinol	35	16
Ondansetron Hcl	Ondansetron Hcl	35	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	31
Glimepiride	Glimepiride	33	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	12
Fluoxetine Hcl	Fluoxetine Hcl	32	12
Glipizide Er	Glipizide	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	14
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	14
Ondansetron Odt	Ondansetron	26	12
Pregabalin	Pregabalin	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Azithromycin	Azithromycin	22	20
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Finasteride	Finasteride	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Trulicity	Dulaglutide	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Fluconazole	Fluconazole	17	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Topiramate	Topiramate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Chlorthalidone	Chlorthalidone	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Cephalexin	Cephalexin	13	13
Lacosamide	Lacosamide	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Baclofen	Baclofen	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error